Prime Editing Guide RNA for Precise HDR-Free Genome Writing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genome editing technologies face challenges in precision editing of single nucleotide mutations, including low efficiency in homology directed repair (HDR), generation of chromosomal rearrangements, and limitations of base editors such as bystander editing and target nucleotide product mixtures, limiting their therapeutic potential.

Innovation Solution

The development of prime editing, which uses a nucleic acid programmable DNA binding protein (napDNAbp) in conjunction with a polymerase and a prime editing guide RNA (PEgRNA) to directly write new genetic information into a specified DNA site through target-primed reverse transcription, allowing precise installation of single nucleotide changes and small insertions or deletions without creating double-strand breaks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If homology directed repair (HDR) is used for precision editing, then single base pair editing capability is improved, but editing efficiency in human cell types particularly non-dividing cells deteriorates

Engineering Contradiction:
Improvesingle base pair editing precisionVSAvoidediting efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The invention extracts and eliminates the requirement for homology directed repair (HDR) from the editing process. By using a prime editing guide RNA (PEgRNA) with a primer binding site and a reverse transcription template, the system enables direct reverse transcription at the target site without relying on HDR, thereby maintaining precision while dramatically improving efficiency in human cells including non-dividing cells

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces a reverse transcription template within the PEgRNA as an intermediary element. This template serves as a mediator that allows the polymerase to directly synthesize the edited sequence at the target site, bridging the gap between CRISPR targeting and precise editing without requiring HDR or donor DNA templates

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If CRISPR/Cas systems create double strand breaks for editing, then target site accessibility is improved, but chromosomal rearrangements and cell growth arrest are increased

Engineering Contradiction:
Improvetarget site accessibilityVSAvoidchromosomal rearrangements and cell growth arrest
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The invention converts the harmful effect of double strand breaks into a beneficial process by using a nickase variant that creates only single-strand nicks. The PEgRNA design includes a primer binding site that allows the nicked strand to serve as a primer for reverse transcription, transforming the potentially harmful nick into a useful starting point for precise editing without triggering chromosomal rearrangements or p53-mediated growth arrest

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The invention replaces the mechanical system of double strand break creation with a biochemical system based on reverse transcription. Instead of using Cas9 nuclease to create DSBs, the system uses a nickase with a PEgRNA that contains a reverse transcription template, allowing the polymerase to directly write the edited sequence at the target site through reverse transcription, thereby eliminating the harmful mechanical disruption of DNA

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Prime editing achieves high efficiency and flexibility in genome editing, enabling precise installation of desired nucleotide changes and modifications, expanding the scope of therapeutic applications in genetic disorders.

Implementation Method 1

a reverse transcriptase, and an extended guide RNA, wherein the reverse transcriptase synthesizes a single-strand DNA flap using the extended guide RNA as a template and the target DNA as a primer, thereby incorporating the desired nucleotide change

Methodology Applied
Scientific EffectReverse transcription:

Data Source

PatentUS12624354B2Methods and compositions for prime editing nucleotide sequences
Publication Date: 2026.05.12 THE BROAD INST INC
  • US12624354B2 patent drawing
  • US12624354B2 patent drawing
  • US12624354B2 patent drawing

AI summary

Compositions and methods are provided herein for conducting prime editing of a target DNA molecule (e.g., a genome) that enables the incorporation of a nucleotide change and/or targeted mutagenesis. The compositions include fusion proteins comprising nucleic acid programmable DNA binding proteins (napDNAbp) and a polymerase (e.g., reverse transcriptase), which is guided to a specific DNA sequence by a modified guide RNA, named an PEgRNA. The PEgRNA has been altered (relative to a standard guide RNA) to comprise an extended portion that provides a DNA synthesis template sequence which encodes a single strand DNA flap which is synthesized by the polymerase of the fusion protein and which becomes incorporated into the target DNA molecule.